Apollo Therapeutics
PrivateLast Round
Series C
Extension
12/1/2023
Total Funding Raised
$462M
Company Overview
Apollo Therapeutics is a biopharmaceutical company dedicated to transforming fundamental medical research into innovative medicines, developing a diverse portfolio of pre-clinical and clinical-stage assets in oncology, major inflammatory disorders, and rare diseases to enhance patient treatments and outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apollo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Apollo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | 12/1/2023 | ||||
| Series C | 9/6/2023 | ||||
| Series B | 6/17/2021 | ||||
| Corporate Funding | 1/25/2016 |
Apollo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Patient Square Capital | Series C Extension, Series C, Series B |
| Reimagined Ventures | Series B |
| Imperial College London | Corporate Funding |
| M&G Investments | Series C |
| Imperial Innovations | Corporate Funding |
| University College London | Corporate Funding |
| Rock Springs Capital | Series C Extension, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2025
Developing a monoclonal antibody treatment for pulmonary arterial hypertension (PAH).
- May 5, 2025
Collaborating with Imperial College London on new antibody treatment.
Apollo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apollo Therapeutics's valuation, stock price, and market status.
